+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Binge Eating Disorder Market - Global Forecast 2026-2032- Product Image
Binge Eating Disorder Market - Global Forecast 2026-2032- Product Image
New

Binge Eating Disorder Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 187 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5968299
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The binge eating disorder market is entering a period of significant transformation, shaped by a blend of therapeutic advancements and a shift toward integrated, technology-enabled care solutions. Across the industry, senior decision-makers are focusing on scalable interventions and optimized patient experiences to address evolving clinical and operational demands.

Market Snapshot: Binge Eating Disorder Market Size and Growth

The Binge Eating Disorder Market expanded from USD 623.43 million in 2025 to USD 664.80 million in 2026, marking ongoing growth driven by innovation and rising demand. With a projected CAGR of 6.22%, the market is anticipated to reach USD 951.57 million by 2032. This growth is propelled by increased clinical recognition of binge eating disorder, advances in digital health applications, and evolving reimbursement frameworks that are prompting strategic realignments for stakeholders. Decision-makers are responding to these factors by adopting integrated technologies and focusing on improved care models that promise both measurable outcomes and operational efficiency.

Binge Eating Disorder Market Scope & Segmentation

This comprehensive report examines the binge eating disorder market across several critical dimensions, providing actionable insights for investment, care delivery, and operational strategy:

  • Therapeutic Modalities: Digital therapeutics, available as mobile apps and web-based platforms, alongside pharmacotherapy—including antidepressants, antiepileptics, and stimulants—and psychological therapies such as cognitive behavioral therapy, dialectical behavior therapy, and interpersonal psychotherapy.
  • Distribution Channels: Home healthcare, hospitals and clinics, online platforms, and specialty treatment centers, each tailored to meet different patient accessibility and scalability needs.
  • End Users: Solutions address specific requirements of adolescents, adults, and elderly populations, enabling tailored therapeutic approaches.
  • Treatment Settings: Inpatient and outpatient environments support a spectrum of care intensities, from acute intervention to ongoing management.
  • Geographies: Analysis spans the Americas, Europe, Middle East & Africa, and Asia-Pacific, considering both regional market nuances and regulatory variation.

Further analysis considers the expanding role of digital engagement tools, adaptive payer models, and local implementation strategies necessary for adoption across health systems with diverse infrastructure and reimbursement landscapes.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Adoption of integrated digital therapeutics advances patient engagement and supports care delivery beyond traditional settings, enabling tailored and scalable interventions.
  • Alignment across payers, providers, and technology innovators drives outcome-based pilots and new value-based reimbursement models, which require standardized measurement and cross-sector collaboration.
  • Pharmaceutical and digital treatment options are increasingly designed for specific patient subgroups, supporting targeted resource allocation and improvements in care precision.
  • Adoption rates and implementation strategies differ markedly by region, reflecting diverse levels of digital readiness, regulatory frameworks, and health technology assessment pathways.
  • Collaborative networks among technology developers, healthcare providers, and payers are accelerating the generation of real-world evidence and supporting the evolution of outcome-driven care models.
  • Stakeholder initiatives increasingly focus on interoperability and establishing robust data standards, streamlining value-based contracting processes and facilitating measurable clinical outcomes.

Tariff Impact: Supply Chain and Procurement Dynamics in 2025

In 2025, U.S. tariff policy adjustments resulted in notable disruptions to procurement processes and supply chains for digital and medical devices integral to binge eating disorder management. Healthcare providers and specialty centers responded by emphasizing domestic sourcing strategies, negotiating long-term supplier agreements, and investigating opportunities for localized digital platform manufacturing. This volatility underscored the critical importance of flexible contracting structures, inclusion of risk-sharing provisions, and agile procurement methods to maintain reliable patient access and help mitigate cost volatility throughout the treatment chain.

Binge Eating Disorder Market Methodology & Data Sources

This report leverages a robust mixed-methods approach combining peer-reviewed literature, the latest regulatory updates, and targeted interviews with clinicians and payer executives. Emphasis is placed on evidence from clinical trials, pragmatic implementation studies, and expert insights. The methodology covers thematic analysis and gap assessment, ensuring clear endpoint definitions and transparent inclusion criteria for all data considered.

Why This Report Matters for Decision Makers

  • Clarifies the evolving binge eating disorder market landscape, aligning technological, therapeutic, and policy developments for strategic decision-making.
  • Supports informed investments and partnerships by illustrating the intersection of clinical needs, commercial potential, and payer priorities.
  • Delivers a practical framework for scaling integrated care models and maintaining competitive positioning in a complex, regulated sector.

Binge Eating Disorder Market: Conclusion

With evolving therapies, innovative delivery channels, and enhanced collaboration across sectors, the binge eating disorder market is poised for measurable advances in access and clinical outcomes. Prioritizing evidence-based approaches and digital integration remains essential for organizations focused on scalable, patient-centered care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Binge Eating Disorder Market, by Treatment Type
8.1. Digital Therapeutics
8.1.1. Mobile App
8.1.2. Web Based
8.2. Pharmacotherapy
8.2.1. Antidepressants
8.2.2. Antiepileptics
8.2.3. Stimulants
8.3. Psychotherapy
8.3.1. Cognitive Behavioral Therapy
8.3.2. Dialectical Behavior Therapy
8.3.3. Interpersonal Psychotherapy
9. Binge Eating Disorder Market, by Treatment Setting
9.1. Inpatient
9.2. Outpatient
10. Binge Eating Disorder Market, by Distribution Channel
10.1. Home Healthcare
10.2. Hospitals And Clinics
10.3. Online Platforms
10.4. Specialty Treatment Centers
11. Binge Eating Disorder Market, by End User
11.1. Adolescents
11.2. Adults
11.3. Elderly
12. Binge Eating Disorder Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Binge Eating Disorder Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Binge Eating Disorder Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Binge Eating Disorder Market
16. China Binge Eating Disorder Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Alsana, Inc.
17.6. Amneal Pharmaceuticals, Inc.
17.7. Apotex Inc. by SK Capital Partners LLP
17.8. BALANCE Eating Disorder Treatment Center
17.9. Carolina House Eating Disorder Treatment Center
17.10. Center for Change
17.11. Equip Health, Inc.
17.12. Hikma Pharmaceuticals PLC
17.13. Jazz Pharmaceuticals plc
17.14. Johnson & Johnson Innovative Medicine by Johnson and Johnson
17.15. Monte Nido & Affiliates Holdings, LLC
17.16. Montecatini Eating Disorder Treatment Center
17.17. Novo Nordisk A/S
17.18. Pfizer Inc.
17.19. Red Oak Recovery
17.20. Rhodes Pharmaceuticals L.P. by Purdue Pharma L.P.
17.21. SimSon Pharma Limited
17.22. Sunovion Pharmaceuticals Inc. by Sumitomo Pharma
17.23. Takeda Pharmaceutical Company Limited
17.24. TalktoAngel
17.25. The London Centre for Eating Disorders and Body Image Ltd.
17.26. TheraCryf Plc
17.27. Timberline Knolls Residential Treatment Center
17.28. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL BINGE EATING DISORDER MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BINGE EATING DISORDER MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BINGE EATING DISORDER MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY TREATMENT SETTING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES BINGE EATING DISORDER MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA BINGE EATING DISORDER MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BINGE EATING DISORDER MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY MOBILE APP, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY MOBILE APP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY MOBILE APP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY WEB BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY WEB BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY WEB BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY PHARMACOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY PHARMACOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY PHARMACOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ANTIEPILEPTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ANTIEPILEPTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ANTIEPILEPTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY STIMULANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY STIMULANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY STIMULANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY DIALECTICAL BEHAVIOR THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY DIALECTICAL BEHAVIOR THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY DIALECTICAL BEHAVIOR THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY INTERPERSONAL PSYCHOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY INTERPERSONAL PSYCHOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY INTERPERSONAL PSYCHOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY INPATIENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY INPATIENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY INPATIENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY OUTPATIENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY OUTPATIENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ONLINE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ONLINE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY SPECIALTY TREATMENT CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY SPECIALTY TREATMENT CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY SPECIALTY TREATMENT CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ADOLESCENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ADOLESCENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ELDERLY, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ELDERLY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ELDERLY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA BINGE EATING DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA BINGE EATING DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA BINGE EATING DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA BINGE EATING DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA BINGE EATING DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA BINGE EATING DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA BINGE EATING DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA BINGE EATING DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA BINGE EATING DISORDER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA BINGE EATING DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA BINGE EATING DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2032 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA BINGE EATING DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA BINGE EATING DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 102. EUROPE BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. EUROPE BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 104. EUROPE BINGE EATING DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 105. EUROPE BINGE EATING DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 106. EUROPE BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2032 (USD MILLION)
TABLE 107. EUROPE BINGE EATING DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 108. EUROPE BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 109. EUROPE BINGE EATING DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. MIDDLE EAST BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 112. MIDDLE EAST BINGE EATING DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST BINGE EATING DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST BINGE EATING DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST BINGE EATING DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 118. AFRICA BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. AFRICA BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 120. AFRICA BINGE EATING DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 121. AFRICA BINGE EATING DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 122. AFRICA BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2032 (USD MILLION)
TABLE 123. AFRICA BINGE EATING DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 124. AFRICA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 125. AFRICA BINGE EATING DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. ASEAN BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. ASEAN BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 137. ASEAN BINGE EATING DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 138. ASEAN BINGE EATING DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 139. ASEAN BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2032 (USD MILLION)
TABLE 140. ASEAN BINGE EATING DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 141. ASEAN BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 142. ASEAN BINGE EATING DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. GCC BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GCC BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 145. GCC BINGE EATING DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 146. GCC BINGE EATING DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 147. GCC BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2032 (USD MILLION)
TABLE 148. GCC BINGE EATING DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 149. GCC BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 150. GCC BINGE EATING DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION BINGE EATING DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION BINGE EATING DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION BINGE EATING DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION BINGE EATING DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 159. BRICS BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. BRICS BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 161. BRICS BINGE EATING DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 162. BRICS BINGE EATING DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 163. BRICS BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2032 (USD MILLION)
TABLE 164. BRICS BINGE EATING DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 165. BRICS BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 166. BRICS BINGE EATING DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. G7 BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. G7 BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 169. G7 BINGE EATING DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 170. G7 BINGE EATING DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 171. G7 BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2032 (USD MILLION)
TABLE 172. G7 BINGE EATING DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 173. G7 BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 174. G7 BINGE EATING DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 175. NATO BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. NATO BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 177. NATO BINGE EATING DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 178. NATO BINGE EATING DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 179. NATO BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2032 (USD MILLION)
TABLE 180. NATO BINGE EATING DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 181. NATO BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 182. NATO BINGE EATING DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. UNITED STATES BINGE EATING DISORDER MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 185. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 186. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 187. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 188. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2032 (USD MILLION)
TABLE 189. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 190. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 191. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. CHINA BINGE EATING DISORDER MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 193. CHINA BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 194. CHINA BINGE EATING DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 195. CHINA BINGE EATING DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 196. CHINA BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2032 (USD MILLION)
TABLE 197. CHINA BINGE EATING DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2032 (USD MILLION)
TABLE 198. CHINA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 199. CHINA BINGE EATING DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Binge Eating Disorder market report include:
  • Alsana, Inc.
  • Amneal Pharmaceuticals, Inc.
  • Apotex Inc. by SK Capital Partners LLP
  • BALANCE Eating Disorder Treatment Center
  • Carolina House Eating Disorder Treatment Center
  • Center for Change
  • Equip Health, Inc.
  • Hikma Pharmaceuticals PLC
  • Jazz Pharmaceuticals plc
  • Johnson & Johnson Innovative Medicine by Johnson and Johnson
  • Monte Nido & Affiliates Holdings, LLC
  • Montecatini Eating Disorder Treatment Center
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Red Oak Recovery
  • Rhodes Pharmaceuticals L.P. by Purdue Pharma L.P.
  • SimSon Pharma Limited
  • Sunovion Pharmaceuticals Inc. by Sumitomo Pharma
  • Takeda Pharmaceutical Company Limited
  • TalktoAngel
  • The London Centre for Eating Disorders and Body Image Ltd.
  • TheraCryf Plc
  • Timberline Knolls Residential Treatment Center
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages187
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 664.8 Million
Forecasted Market Value ( USD ) by 2032 $ 951.57 Million
Compound Annual Growth Rate6.2%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Binge Eating Disorder Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Binge Eating Disorder Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 185 Pages
  • Global
From
Binge-Eating Disorder - Pipeline Insight, 2025 - Product Image

Binge-Eating Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Binge Eating Disorder Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034) - Product Image

Binge Eating Disorder Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Binge Eating Disorders Market - A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035 - Product Image

Binge Eating Disorders Market - A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035

  • Report
  • Global
From
Binge-Eating Disorder Treatment Market 2025-2029 - Product Image

Binge-Eating Disorder Treatment Market 2025-2029

  • Report
  • 218 Pages
  • Global
From

About the Binge Eating Disorder Market

Binge Eating Disorder (BED) is a mental health disorder characterized by recurrent episodes of eating large amounts of food in a short period of time, accompanied by feelings of guilt, shame, and distress. BED is the most common eating disorder in the United States, affecting an estimated 3.5% of adults. It is more common in women than men, and is associated with a range of physical and psychological health problems. Treatment for BED typically involves a combination of psychotherapy, nutritional counseling, and medication. Cognitive Behavioral Therapy (CBT) is the most commonly used form of psychotherapy, and is designed to help individuals identify and modify unhealthy eating behaviors. Nutritional counseling focuses on helping individuals develop healthy eating habits and improve their relationship with food. Medications such as antidepressants and anti-obesity drugs may also be used to help reduce binge eating episodes. There are a number of companies that provide services related to BED, including online therapy providers, nutritionists, and pharmaceutical companies. Examples include Talkspace, NutriSavings, and Orexigen Therapeutics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.